Stereoselectivity in (Z)-Vinylmetal Additions to C1–C9 β-Silyloxy Aldehyde
chromatography: 8:2 hexane/EtOAc. Yield: 14 mg (92%). Rf = 0.51
(1:1 hexane/EtOAc). [α]2D5 = +33.0 (c = 0.57 CH2Cl2). 1H NMR
(400 MHz, CDCl3): δ = 7.35 (dd, J = 15.4, 11.3 Hz, 1 H), 7.30–
7.18 (m, 5 H), 6.56 (t, J = 11.3 Hz, 1 H), 6.09 (dd, J = 15.5, 7.8 Hz,
1 H), 5.59 (d, J = 11.3 Hz, 1 H), 5.50–5.43 (m, 2 H), 4.50 (dd, J =
13.8, 5.5 Hz, 1 H), 3.75–3.73 (m, 1 H), 3.71 (s, 3 H), 3.59 (m, 1 H),
2.91 (dd, J = 13.9, 3.7 Hz, 1 H, AB system), 2.66 (dd, J = 13.9,
7.3 Hz, 1 H, AB system), 2.49 (m, 1 H), 2.38 (dd, J = 12.8, 6.7 Hz,
1 H), 2.32 (br. s, 1 H), 1.39–1.35 (m, 2 H), 1.34 (s, 3 H), 1.30 (s, 3
H), 1.05 (d, J = 6.8 Hz, 6 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 167.0 (C0), 146.8 (CH), 145.5 (CH), 138.6 (C0), 135.6 (CH),
131.4 (CH), 129.8 (CH), 128.3 (CH), 126.9 (CH), 126.2 (CH), 115.5
(CH), 98.7 (C0), 75.0 (CH), 71.9 (CH), 65.2 (CH), 51.1 (CH3), 41.8
(CH), 40.5 (CH2), 37.8 (CH), 34.1 (CH2), 30.0 (CH3), 19.5 (CH3),
17.7 (CH3), 15.5 (CH3) ppm. HRMS (ESI): calcd. for C26H36O5Na
[M + Na]+ 451.24550; found 451.24564.
30.2 (CH3), 19.7 (CH3), 17.3 (CH3), 15.5 (CH3) ppm. HRMS (ESI):
calcd. for C26H36O5Na [M + Na]+ 451.24550; found 451.24586.
(2Z,4E,6R,7S,9S,10Z,12S,13S,14S)-Methyl-7,13-bis(tert-butyl-
dimethylsilyloxy)-9-hydroxy-6,12-dimethyl-14-phenylpentadeca-
2,4,10-trienoate [14c, 7,9-anti (9S)] and (2Z,4E,6R,7S,9R,
10Z,12S,13S,14S)-Methyl-7,13-bis(tert-butyldimethylsilyloxy)-9-hy-
droxy-6,12-dimethyl-14-phenylpentadeca-2,4,10-trienoate [14c, 7,9-
syn (9R)]: Prepared by following General Procedure 5b. Flash
chromatography: 96:4 hexane/EtOAc. Yield: 68 mg (69% yield by
1H NMR) of 9-epimeric products, dr [7,9-anti (9S)/7,9-syn (9R)] =
57:43. Data for 14c 7,9-anti (9S): Rf = 0.31 (85:15 hexane/EtOAc).
1
[α]3D0 = +1.4 (c = 0.18 CHCl3). H NMR (400 MHz, CDCl3): δ =
7.37 (dd, J = 15.3, 11.3 Hz, 1 H), 7.26–7.09 (m, 5 H), 6.56 (t, J =
11.3 Hz, 1 H), 6.02 (dd, J = 15.5, 7.5 Hz, 1 H), 5.59 (m, 2 H), 5.32
(m, 1 H), 4.35 (dd, J = 13.1, 8.3 Hz, 1 H), 3.89 (dd, J = 10.4,
5.1 Hz, 1 H), 3.73 (s, 3 H), 3.67 (dd, J = 7.1, 3.2 Hz, 1 H), 2.79
(m, 1 H), 2.54 (m, 2 H), 1.91 (br. s, 1 H), 1.45 (m, 2 H), 1.24 (d, J
= 7.1 Hz, 3 H), 1.02 (d, J = 6.8 Hz, 3 H), 1.01 (d, J = 7.0 Hz, 3
(2Z,4E,6R,7S,9S,10Z,12R,13S)-Methyl-7,13-bis(tert-butyldimethyl-
silyloxy)-9-hydroxy-6,12-dimethyl-14-phenyltetradeca-2,4,10-tri-
enoate [14b, 7,9-anti (9S)] and (2Z,4E,6R,7S,9R,10Z,12R,13S)- H), 0.92 (s, 9 H), 0.84 (s, 9 H), 0.05 (s, 6 H), 0.03 (s, 3 H), –0.14
Methyl-7,13-bis(tert-butyldimethylsilyloxy)-9-hydroxy-6,12-di-
methyl-14-phenyltetradeca-2,4,10-trienoate [14b, 7,9-syn (9R)]: Pre-
pared by following General Procedure 5b. Flash chromatography:
96:4 hexane/EtOAc. Yield: 132 mg (66% yield by 1H NMR) of a
mixture of inseparable 9-epimeric products and unreacted 5, dr
[7,9-anti (9S)/7,9-syn (9R)] = 86:14. Rf = 0.32 (85:15 hexane/
EtOAc). HRMS (ESI): calcd. for C35H60O5Si2Na [M + Na]+
639.38715; found 639.38812.
(s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 166.9 (C0), 147.4
(CH), 145.4 (CH), 145.3 (C0), 133.2 (CH), 132.2 (CH), 128.3 (CH),
127.8 (CH), 126.7 (CH), 126.2 (CH), 115.7 (CH), 80.7 (CH), 72.7
(CH), 64.5 (CH), 51.1 (CH3), 44.2 (CH), 42.7 (CH), 39.7 (CH2),
36.2 (CH), 26.3 (CH3), 25.9 (CH3), 20.1 (CH3), 18.5 (C0), 18.1
(CH3), 18.0 (C0), 14.6 (CH3), –3.2 (CH3), –4.0 (CH3), –4.5 (CH3),
–4.6 (CH3) ppm. HRMS (ESI): calcd. for C36H62O5Si2Na [M +
Na]+ 653.40280; found 653.40322. Data for 14c 7,9-syn (9R): Rf =
0.45 (85:15 hexane/EtOAc). [α]3D0 = +8.0 (c = 0.21 CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 7.34–7.20 (m, 6 H), 6.49 (t, J =
11.3 Hz, 1 H), 5.94 (dd, J = 15.5, 8.3 Hz, 1 H), 5.57 (d, J = 11.3 Hz,
1 H), 5.46 (t, J = 10.6 Hz, 1 H), 5.30 (dd, J = 11.1, 8.4 Hz, 1 H),
3.84 (t, J = 7.9 Hz, 1 H), 3.78–3.69 (m, 2 H), 3.73 (s, 3 H), 2.78
(m, 1 H), 2.37 (m, 2 H), 1.86 (br. s, 1 H), 1.56 (m, 1 H), 1.25 (d, J
= 7.0 Hz, 3 H), 1.24–1.21 (m, 1 H), 1.03 (d, J = 6.8 Hz, 3 H), 0.94
(s, 9 H), 0.89 (s, 9 H), 0.81 (d, J = 7.0 Hz, 3 H), 0.07 (s, 3 H), 0.06
(s, 3 H), 0.05 (s, 3 H), 0.00 (s, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 166.6 (C0), 146.8 (CH), 145.7 (C0), 145.5 (CH), 132.8
(CH), 131.9 (CH), 128.4 (CH), 128.1 (CH), 127.0 (CH), 126.2
(CH), 115.4 (CH), 80.5 (CH), 73.9 (CH), 65.8 (CH), 51.0 (CH3),
45.0 (CH), 41.8 (CH), 41.3 (CH2), 35.9 (CH), 26.3 (CH3), 25.8
(CH3), 20.0 (CH3), 19.9 (CH3), 18.5 (C0), 18.0 (C0), 15.7 (CH3),
–3.2 (CH3), –3.6 (CH3), –4.4 (CH3), –4.4 (CH3) ppm. HRMS (ESI):
calcd. for C36H62O5Si2Na [M + Na]+ 653.40280; found 653.40313.
(R,2Z,4E)-Methyl-6-[(4S,6S)-6-{(3R,4S,Z)-4-hydroxy-3-methyl-
5-phenylpent-1-enyl}-2,2-dimethyl-1,3-dioxan-4-yl]hepta-2,4-di-
enoate [15b, 7,9-anti (9S)] and (R,4E)-Methyl-6-[(4S,6R)-6-
{(3R,4S,Z)-4-hydroxy-3-methyl-5-phenylpent-1-enyl}-2,2-dimethyl-
1,3-dioxan-4-yl]hepta-2,4-dienoate [15b, 7,9-syn (9R)]: Prepared by
following General Procedure 6. Flash chromatography: 95:5
CH2Cl2/EtOAc. Yield: 69 mg (95%) of 9-epimeric products. Data
for 15b 7,9-anti (9S): Rf = 0.18 (95:5 CH2Cl2/EtOAc). [α]2D6 = –112.7
1
(c = 1.02 CH2Cl2). H NMR (400 MHz, CDCl3): δ = 7.39 (dd, J
= 15.4, 11.3 Hz, 1 H), 7.32–7.20 (m, 5 H), 6.56 (t, J = 11.3 Hz, 1
H), 6.09 (dd, J = 15.5, 7.7 Hz, 1 H), 5.61 (d, J = 11.3 Hz, 1 H),
5.56–5.47 (m, 2 H), 4.51 (dd, J = 15.5, 6.5 Hz, 1 H), 3.76 (m, 1 H),
3.72 (s, 3 H), 3.62 (m, 1 H), 2.89 (dd, J = 13.8, 3.5 Hz, 1 H, AB
system), 2.65 (dd, J = 13.8, 8.3 Hz, 1 H, AB system), 2.55 (m, 1
H), 2.41 (m, 1 H), 2.12 (br. s, 1 H), 1.77–1.63 (m, 2 H), 1.33 (s, 3
H), 1.31 (s, 3 H), 1.08 (d, J = 5.8 Hz, 3 H), 1.06 (d, J = 6.2 Hz, 3
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 166.9 (C0), 146.9 (CH), (R,2Z,4E)-Methyl-6-[(4S,6S)-6-{(3S,4S,5S,Z)-4-hydroxy-3-methyl-
145.5 (CH), 138.7 (C0), 134.7 (CH), 131.4 (CH), 129.5 (CH), 128.3 5-phenylhex-1-enyl}-2,2-dimethyl-1,3-dioxan-4-yl]hepta-2,4-dienoate
(CH), 126.9 (CH), 126.2 (CH), 115.6 (CH), 100.5 (C0), 75.3 (CH),
[15c, 7,9-anti (9S)]: Prepared by following General Procedure 6.
69.6 (CH), 63.2 (CH), 51.0 (CH3), 41.6 (CH), 40.9 (CH2), 37.9 Flash chromatography: 8:2 hexane/EtOAc. Yield: 16 mg (98%). Rf
(CH), 36.5 (CH2), 25.1 (CH3), 24.4 (CH3), 17.7 (CH3), 15.6 (CH3)
ppm. HRMS (ESI): calcd. for C26H36O5Na [M + Na]+ 451.24550;
found 451.24505. Data for 15b 7,9-syn (9R): Rf = 0.10 (95:5
CH2Cl2/EtOAc). [α]2D6 = –31.4 (c = 0.70 CH2Cl2). 1H NMR
= 0.48 (1:1 hexane/EtOAc). [α]2D6 = –45.1 (c = 0.71 CH2Cl2). 1H
NMR (400 MHz, CDCl3): δ = 7.41 (dd, J = 15.5, 11.3 Hz, 1 H),
7.30–7.16 (m, 5 H), 6.60 (t, J = 11.4 Hz, 1 H), 6.08 (dd, J = 15.5,
7.7 Hz, 1 H), 5.63 (d, J = 11.3 Hz, 1 H), 5.60–5.44 (m, 2 H), 4.21
(400 MHz, CDCl3): δ = 7.40 (dd, J = 15.6, 11.4 Hz, 1 H), 7.35– (dd, J = 15.0, 8.5 Hz, 1 H), 3.73 (s, 3 H), 3.69 (m, 1 H), 3.52 (t, J
7.24 (m, 5 H), 6.61 (t, J = 11.3 Hz, 1 H), 6.14 (dd, J = 15.5, 7.7 Hz, = 5.9 Hz, 1 H), 2.80 (p, J = 6.9 Hz, 1 H), 2.50 (m, 1 H), 2.40 (m,
1 H), 5.63 (d, J = 11.3 Hz, 1 H), 5.55–5.48 (m, 2 H), 4.58 (m, 1 1 H), 1.68–1.54 (m, 3 H), 1.30 (d, J = 6.9 Hz, 3 H), 1.30 (s, 3 H),
H), 3.79 (m, 1 H), 3.74 (s, 3 H), 3.65 (m, 1 H), 2.90 (dd, J = 13.8,
1.23 (s, 3 H), 1.06 (d, J = 6.9 Hz, 3 H), 1.04 (d, J = 6.9 Hz, 3 H)
3.4 Hz, 1 H, AB system), 2.69–2.61 (m, 2 H), 2.42 (m, 1 H), 1.71 ppm. 13C NMR (100 MHz, CDCl3): δ = 166.9 (C0), 147.1 (CH),
(br. s, 1 H), 1.45 (s, 3 H), 1.41 (s, 3 H), 1.38–1.35 (m, 2 H), 1.13 145.5 (CH), 144.8 (C0), 134.5 (CH), 130.9 (CH), 128.4 (CH), 127.7
(d, J = 6.7 Hz, 3 H), 1.09 (t, J = 6.2 Hz, 3 H) ppm. 13C NMR
(CH), 126.9 (CH), 126.4 (CH), 115.6 (CH), 100.4 (C0), 79.1 (CH),
(100 MHz, CDCl3): δ = 166.9 (C0), 146.9 (CH), 145.6 (CH), 138.6 69.7 (CH), 63.2 (CH), 51.1 (CH3), 42.9 (CH), 41.4 (CH), 36.2
(C0), 134.4 (CH), 131.6 (CH), 129.4 (CH), 128.5 (CH), 126.8 (CH),
126.5 (CH), 115.5 (CH), 98.6 (C0), 75.6 (CH), 71.9 (CH), 65.6
(CH2), 35.7 (CH), 24.8 (CH3), 24.4 (CH3), 18.2 (CH3), 16.2 (CH3),
15.6 (CH3) ppm. HRMS (ESI): calcd. for C27H38O5Na [M + Na]+
(CH), 51.1 (CH3), 41.9 (CH), 40.7 (CH2), 38.2 (CH), 34.2 (CH2), 465.26115; found 465.26058.
Eur. J. Org. Chem. 2012, 144–153
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
151